13F HOLDINGS REPORT
Opaleye Management Inc.
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001493152-24-032150
Total Value
$437.7M
Positions
51
Other Managers
0
Confidential Omitted
No
Holdings (51)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HARROW HEALTH INC | HROW | 3,990,000 | $83.4M | 19.04% |
| 2 | TG THERAPEUTICS INC | TGTX | 2,280,000 | $40.6M | 9.27% |
| 3 | OCULAR THERAPEUTIX INC | OCUL | 5,307,500 | $36.3M | 8.29% |
| 4 | RHYTHM PHARMACEUTICALS INC | RYTM | 515,000 | $21.1M | 4.83% |
| 5 | KEROS THERAPEUTICS INC | KROS | 367,500 | $16.8M | 3.84% |
| 6 | ARVINAS INC | ARVN | 555,000 | $14.8M | 3.38% |
| 7 | IMMUNOME INC | IMNM | 1,102,500 | $13.3M | 3.05% |
| 8 | CYTOKINETICS INC | CYTK | 198,500 | $10.8M | 2.46% |
| 9 | CODEXIS INC | CDXS | 3,455,000 | $10.7M | 2.45% |
| 10 | EDGEWISE THERAPEUTICS INC | EWTX | 580,000 | $10.4M | 2.39% |
| 11 | CATALYST PHARMACEUTICALS INC | CPRX | 640,000 | $9.9M | 2.27% |
| 12 | CARGO THERAPEUTICS INC | 14179K101 | 555,700 | $9.1M | 2.08% |
| 13 | JASPER THERAPEUTICS INC | JSPRW | 392,000 | $8.9M | 2.03% |
| 14 | NURIX THERAPEUTICS INC | NRIX | 418,928 | $8.7M | 2.00% |
| 15 | TREVI THERAPEUTICS INC | TRVI | 2,645,000 | $7.9M | 1.80% |
| 16 | ETON PHARMACEUTICALS INC | ETON | 2,395,000 | $7.9M | 1.80% |
| 17 | APPLIED THERAPEUTICS INC' | 03828A101 | 1,680,000 | $7.8M | 1.79% |
| 18 | 4D MOLECULAR THERAPEUTICS INC | FDMT | 345,750 | $7.3M | 1.66% |
| 19 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 897,000 | $7.2M | 1.64% |
| 20 | ACELYRIN INC | 00445A100 | 1,580,000 | $7.0M | 1.59% |
| 21 | UROGEN PHARMA LTD | URGN | 412,000 | $6.9M | 1.58% |
| 22 | VAXCYTE INC | PCVX | 85,000 | $6.4M | 1.47% |
| 23 | BIODESIX INC | BDSX | 4,020,000 | $6.2M | 1.41% |
| 24 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 315,000 | $6.1M | 1.38% |
| 25 | XOMA CORP DEL | XOMAP | 250,000 | $5.9M | 1.35% |
| 26 | PROTARA THERAPEUTICS INC | TARA | 2,304,262 | $5.3M | 1.21% |
| 27 | INTELLIA THERAPEUTICS INC | NTLA | 218,000 | $4.9M | 1.11% |
| 28 | NUVALENT INC | NUVL | 59,300 | $4.5M | 1.03% |
| 29 | SYROS PHARMACEUTICALS INC | 87184Q206 | 865,443 | $4.5M | 1.02% |
| 30 | GOSSAMER BIO INC | GOSS | 8,000,000 | $4.0M | 0.90% |
| 31 | LIQUIDIA CORPORATION | LQDA | 325,000 | $3.9M | 0.89% |
| 32 | KARYOPHARM THERAPEUTICS INC | KPTI | 6,000,000 | $3.7M | 0.86% |
| 33 | PROTAGONIST THERAPEUTICS INC | PTGX | 105,000 | $3.6M | 0.83% |
| 34 | GOSSAMER BIO INC | GOSS | 3,910,000 | $3.5M | 0.80% |
| 35 | LEXICON PHARMACEUTICALS INC | LXRX | 1,875,000 | $3.1M | 0.72% |
| 36 | SAVARA INC | SVRA | 714,960 | $2.9M | 0.66% |
| 37 | ALLAKOS INC | 01671P100 | 2,780,000 | $2.8M | 0.64% |
| 38 | VENTYX BIOSCIENCES INC | 92332V107 | 1,190,000 | $2.7M | 0.63% |
| 39 | VERASTEM INC | VSTM | 915,000 | $2.7M | 0.62% |
| 40 | REGULUS THERAPEUTICS INC | 75915K309 | 1,475,000 | $2.6M | 0.60% |
| 41 | LYELL IMMUNOPHARMA INC | LYEL | 1,670,000 | $2.4M | 0.55% |
| 42 | RELMADA THERAPEUTICS INC | RLMD | 600,000 | $1.8M | 0.41% |
| 43 | FULCRUM THERAPEUTICS INC | FULC | 285,000 | $1.8M | 0.40% |
| 44 | KARYOPHARM THERAPEUTICS INC | KPTI | 1,425,000 | $1.2M | 0.28% |
| 45 | IBIO INC | IBIO | 375,000 | $791,250 | 0.18% |
| 46 | PMV PHARMACEUTICALS INC | PMVP | 475,000 | $769,500 | 0.18% |
| 47 | AEROVATE THERAPEUTICS INC | 008064107 | 440,000 | $730,400 | 0.17% |
| 48 | DESIGN THERAPEUTICS INC | DSGN | 205,000 | $686,750 | 0.16% |
| 49 | ABCELLERA BIOLOGICS INC | ABCL | 200,000 | $592,000 | 0.14% |
| 50 | ALIGOS THERAPEUTICS INC | ALGS | 1,260,000 | $441,000 | 0.10% |
| 51 | RENEO PHARMACEUTICALS INC | 75974E103 | 165,000 | $249,150 | 0.06% |